Американское общество гирудотерапии

Continuous postoperative monitoring of cutaneous free flaps using near infrared spectroscopy.

Research article published in Journal of plastic, reconstructive & aesthetic surgery : JPRAS (2007)

Последнее обновление: June 18, 2026Рецензент: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportКлинические исследованияRepez et al. · Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 2007

Abstract

UNLABELLED: Reliable detection of circulatory compromise threatening free-flap viability is essential for prompt surgical intervention and flap salvage. Numerous techniques have been developed to address the issue of postoperative flap monitoring but none have achieved universal acceptance. Near infrared spectroscopy (NIRS) is a noninvasive technique that allows continuous monitoring of tissue oxygenation and perfusion. It is increasingly recognised to be a reliable method for flap viability assessment. This study was designed to investigate the ability of NIRS to detect and identify microvascular thrombosis endangering flap survival. To our knowledge, this is the first clinical evaluation of NIRS used for continuous monitoring of free flaps. METHODS: Fifty flaps used for autologous breast reconstruction in 48 patients were included in this prospective clinical study. NIRS was employed for 72-h continuous postoperative monitoring. The data were compared to findings of clinical assessments. RESULTS: Ten flaps (20%) developed 13 anastomosis thromboses (two arterial and 11 venous). NIRS detected all cases of flow failure prior to clinical observation with no false positives or negatives. Based on consistent patterns of NIRS parameter changes, it was possible to differentiate between changes caused by arterial and venous thrombosis with accuracy before surgical re-exploration. The salvage rate was 70%. Overall flap viability was 94%. CONCLUSIONS: Continuous NIRS monitoring can reliably detect and identify early stages of arterial and venous thrombosis, and is a credible method for noninvasive postoperative flap surveillance. Based on these findings, we advocate its use for monitoring of flaps with a cutaneous component.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeEvaluation StudyJournal Article
Indexed MeSH termsAdultFemaleGraft RejectionGraft SurvivalHumansMammaplastyMiddle AgedPostoperative CarePostoperative ComplicationsProspective StudiesSpectroscopy, Near-InfraredSurgical Flaps

Резюме

Reliable detection of circulatory compromise threatening free-flap viability is essential for prompt surgical intervention and flap salvage. Numerous techniques have been developed to address the issue of postoperative flap monitoring but none have achieved universal acceptance.

Почему это важно для гирудотерапии

This prospective clinical study evaluated near-infrared spectroscopy (NIRS) for continuous postoperative monitoring of 50 free flaps used for autologous breast reconstruction in 48 patients over 72 hours. NIRS detected all 13 anastomosis thromboses (2 arterial, 11 venous) before clinical observation with no false positives or negatives, achieving a 70% salvage rate and 94% overall flap viability. The abstract concludes that continuous NIRS monitoring reliably detects early arterial and venous thrombosis and advocates its use for monitoring flaps with a cutaneous component. The abstract contains no mention of leeches, hirudotherapy, or any leech-related content. There is no defensible leech link from this abstract.

Цитирование

Continuous postoperative monitoring of cutaneous free flaps using near infrared spectroscopy.

Repez et al. · Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 2007

Связанный клинический контекст

Добавлено в библиотеку ASH: May 28, 2026 · Последнее обновление сайта: June 18, 2026

Этот сайт предоставляет образовательную информацию и не является медицинской консультацией, диагнозом или рекомендацией по лечению. Гирудотерапия сопряжена с клинически значимыми рисками и должна проводиться только квалифицированными клиницистами в рамках институционально утверждённых протоколов. Разрешение FDA 510(k) для медицинских пиявок ограничено определёнными показаниями; обсуждения исследовательского и нелицензионного применения отмечены соответствующим образом. Для индивидуальных медицинских рекомендаций обратитесь к квалифицированному медицинскому специалисту.